InformEx 2014: Preliminary Conference Agenda
InformEx is proud to announce our 2014 educational programming. Please see below for our preliminary agenda and check back frequently for further updates!
The market for personalized medicine in the US is already valued at $232 billion and is projected to show double digit CAGR moving forward. For custom manufacturers, this market presents a tremendous opportunity to step up and meet the demand for custom synthesis and diverse raw materials required for specialized drugs and diagnostics. This session will shed light on the opportunities that personalized medicine and companion diagnostics are creating for the industry and how companies can adapt to succeed in this changing environment.
Speaker: Jim Hamby, Business Development at Ash Stevens
The world's largest free trade agreement ever negotiated is underway between the U.S. and the European Union. If successful, this trade deal will have global implications, providing enormous market incentives for U.S. chemical manufacturers. This session details what is at stake for chemical manufacturers and whether differences in chemical and pharmaceutical product regulation between the US and EU governments could hinder the trade agreement's ultimate passage.
Speaker: Bill Allmond, VP of Government and Public Relations at SOCMA
The contract manufacturing sector has, like the drug companies it counts as customers, gone through an intense period of transformation. Drug makers have also reorganized in fundamental ways in order to prepare for the avalanche of patent expiries that occurred last year. While the reformed drug industry had a very tough 2013, the CMO sector, constituting a leading economic indicator for pharmaceuticals, is optimistic. I would like to give a presentation that investigates whether a fundamentally new drug industry is in a secure enough position to grow, and also investigate where in the industry—big pharma, biotech, emerging pharma—new drugs will come from. This will include a survey of what the new molecules look like and the services drug makers will require.
Speaker: Rick Mullin, Senior Editor Chemical & Engineering News
Adopting external technologies at innovator companies can present a number of challenges, but even greater rewards for all parties involved. This session will outline case studies of successful partnerships between external technology provides, and their customers who adopted these technologies to deliver innovative products. A panel will elaborate on examples of innovation, challenges that champions at the innovator companies had to overcome, best practices, lessons learned and a look at why some great external innovations never make it out of the box.
In recent years, a number of the bigger players in the market have left chemical manufacturing for a variety of reasons. As a result, there is money to be made for innovative fine, specialty and custom chemical manufacturers. Patenting innovations in the US is cheap, and more importantly, the process is fairly simple with the right guidance. This session will explore some of the reasons why the industry has an exceptionally bright future, the patent process in the US, and what innovative thinkers should do to commercialize their ideas.
Speakers: Tom Daly, CEO at Crison and Clifford Kraft, Patent Attorney
As retailers move towards highly sophisticated cloud data management systems for regulatory and sustainability information for their products, they are requiring their suppliers to match up their safety information with comprehensive global data. This session dives into the current direction of the industry as retailers shore up chemical supply chain vulnerabilities, the impact on fine and specialty chemicals suppliers, and best practices for maintaining and providing regulatory data.
Continuous Processing as a way of producing fine chemicals, active pharmaceutical ingredients, and finished dosage forms is gaining widespread attention. This method presents a number of potential benefits over traditional batch-wise production. Learn about the biggest opportunities to benefit, the status of implementation, and perceived hurdles affecting implementation of continuous processing among API manufacturers.
New technologies, regulations, consumer and economic factors are driving green chemistry, a market that is set to grow to nearly $100 billion and save the chemical industry over $65 billion by 2020. With opportunities abound to produce industrially relevant compounds with great efficiency and minimal waste, how can fine, specialty and custom chemical makers differentiate themselves in the green chemistry supply chain? This session pin points challenges that need to be overcome, incorporating sustainability principles into processes, and how green chemistry is spurring innovation and co-opetition.
Using free, renewable carbon dioxide as a feedstock is an increasingly attractive option compared to petrochemical alternatives. And now, it is actually becoming economically viable to convert carbon dioxide into commercial chemicals. This session will explore the use of carbon dioxide as a feedstock, and how fine, specialty and custom chemical manufacturers can use such processes to their advantage.
Several federal agencies, including the Environmental Protection Agency (EPA), Department of Homeland Security (DHS), and the Occupational Safety and Health Administration (OSHA), actively work with the industry to promote safer and more secure plants and facilities in the post 9/11 world. Inherently safer manufacturing processes have been a major focus for reducing potential threats to public and worker safety, health, the environment. For the fine and specialty chemicals industry, inherently safer technology not only makes it easier to work with the DHS, but can lead to lower insurance and risk costs while ensuring the safety of customers and employees and protecting your investors from excessive risk.
Printed Electronics, recently valued a $700 million per year industry, is viewed as an industry that is set to take off. Thanks to the numerous functions of fine chemicals within these new electronics, the fine and specialty chemicals industry should stand to gain the most. This session details the biggest needs for the printed electronics industry, and what opportunities exist for players in the fine and specialty chemicals space.
With the emergence of cloud storage and robust data management systems, it is more important than ever for companies to take steps to safeguard their confidential data. Additionally, a sound cybersecurity system creates a level of comfort and reassurance for their customers. This forum will give manufacturers an opportunity to learn about cybersecurity trends and best practices for taking on new threats.